Skip to main content

Table 3 Clinical Characteristics of TIR Quartiles (Q1-Q4)

From: The association between time in the glucose target range and abnormal ankle-brachial index: a cross-sectional analysis

 

Q1

Q2

Q3

Q4

χ2/z

P

N

102

101

101

101

  

Male (n, %)

60, 58.8

66, 65.3

75, 74.3

77, 76.2

9.265

0.026

Age (y)

59.0 (49.8,67.3)

56.0 (48.5,66.0)

53.0 (45.0,61.0)

54.0 (44.0,61.0)

13.301

0.004

Diabetes duration (y)

10.0 (2.8,16.3)

9.0 (4.0,15.0)

7.0 (2.0,12.5)

5.0 (1.0,10.0)

13.398

0.004

BMI

25.20 (22.78,28.10)

24.80 (22.50,26.90)

24.40 (22.90,27.00)

25.20 (22.30,28.15)

2.453

0.484

Hypertension (n, %)

57, 55.9%

53, 52.5%

49, 48.5%

55, 54.5%

1.248

0.741

Smoking (n, %)

25, 27.2%

27, 28.7%

31, 33.0%

32, 34.8%

1.646

0.649

Diabetic retinopathy (n, %)

17, 17.2%

32, 31.7%

17, 17.0%

13, 12.9%

13.006

0.005

Diabetic kidney disease (n, %)

14, 13.7%

16, 15.8%

19, 18.8%

10, 9.9%

3.419

0.331

CRP (mg/L)

0.70 (0.50,2.08)

0.80 (0.50,2.30)

0.75 (0.50,1.85)

1.00 (0.50,2.55)

4.526

0.210

UREA (mmol/L)

5.60 (4.60,6.80)

5.60 (4.40,6.70)

5.85 (5.03,6.88)

5.60 (4.85,6.60)

2.845

0.416

Scr (μmol/L)

54.00 (47.00,70.00)

56.00 (46.95,67.25)

60.00 (50.00,72.83)

62.00 (52.00,71.00)

7.143

0.067

UA (μmol/L)

296.00 (226.00,352.00)

306.00 (260.00,388.50)

314.50 (259.25,390.50)

357.00 (280.00,423.50)

16.728

0.001

ACR

14.10 (7.60,85.50)

12.80 (6.20,72.35)

8.90 (5.10,34.80)

10.90 (5.40,41.05)

9.809

0.020

TC (mmol/L)

4.54 (3.91,5.36)

4.44 (3.74,5.02)

4.38 (3.71,5.06)

4.18 (3.53,5.09)

4.381

0.223

TG (mmol/L)

1.50 (0.98,2.07)

1.49 (0.99,2.16)

1.49 (0.96,2.37)

1.48 (1.07,2.23)

0.321

0.956

HDL (mmol/L)

1.08 (0.92,1.35)

1.05 (0.91,1.25)

1.09 (0.90,1.30)

1.01 (0.89,1.19)

3.430

0.330

LDL (mmol/L)

2.89 ± 0.91

2.71 ± 0.90

2.70 ± 0.92

2.56 ± 0.83

2.282

0.079

HbA1C (%)

9.90 (8.45,10.90)

9.00 (8.00,10.35)

8.20 (7.10,9.70)

7.10 (6.40,8.50)

73.749

 < 0.001

MBG (mmol/L)

11.03 (10.59,11.72)

9.47 (9.09,9.92)

8.33 (7.90,8.76)

7.28 (6.77,7.84)

330.002

 < 0.001

SD (mmol/L)

3.00 (2.43,4.03)

2.69 (2.27,3.28)

2.19 (1.88,2.65)

1.51 (1.31,1.79)

177.368

 < 0.001

MODD (mmol/L)

2.96 (2.22,4.05)

2.42 (1.98,3.15)

1.82 (1.49,2.34)

1.28 (1.01,1.56)

172.215

 < 0.001

MAGE (mmol/L)

5.22 (4.18,6.55)

4.87 (3.85,6.18)

4.65 (3.46,5.53)

3.39 (2.89,4.12)

86.929

 < 0.001

ADDR (mmol/L)

32.87 (27.74,39.30)

26.88 (21.92,30.37)

18.83 (18.83,23.19)

11.65 (8.72,15.32)

237.058

 < 0.001

M value (mmol/L)

17.29 (12.45,25.57)

9.13 (7.12,11.69)

4.34 (3.59,6.18)

1.88 (1.10,2.72)

316.832

 < 0.001

CV[M (QL, QU)]

0.27 (0.22,0.36)

0.29 (0.23,0.35)

0.26 (0.22,0.32)

0.21 (0.,17, 0.26)

55.534

 < 0.001

  1. aBMI: body mass index; CRP: C-reactive protein; Scr: serum creatinine; UA: blood uric acid; ACR: urinary albumin/creatinine ratio; TC: total cholesterol; TG; triglyceride; HDL: high-density lipoprotein; LDL: low‐density lipoprotein; HbA1C: hemoglobin A1C; MBG: mean blood glucose; SD: standard deviation; MODD: mean of daily differences; MAGE: mean amplitude of glucose excursions; ADDR: average daily risk range; CV: coefficient of variation
  2. bContinuous data with normal distribution were expressed in mean ± SD, and inter-group comparison was performed by one-way ANOVA. Abnormal distribution measurement data were expressed as medians (lower and upper quartiles) [M (QL, QU)], and variables among multiple groups were compared by non-parametric Kruskal-Wallis test. The categorical variables were expressed as count (percentages) [N (%)] and χ2 test for which was used
  3. The bolded values in the table highlight results with P value < 0.05
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840